We apologize for any inconvenience:Monday, December 23, 2024 thru Wednesday, January 1, 2025.
Join Interest ListApply Now
June 1, 2024 • Pain Management Section
We take immense pride in the dedication of emergency physicians committed to assisting those with substance use disorders, and who are actively working to mitigate addiction risk by creating pain mana...
January 2, 2024 • Pain Management Section
The section won the ACEP Teamwork Award after passing several resolutions at the 2022 ACEP Scientific Assembly.
March 24, 2023
There were 5 different resolutions passed at the 2022 Council Meeting with relevance to our section. One of our section objectives is to: “Provide guidance and support to assist emergency physicians ...
December 14, 2021 • Pain Management Section
We are very pleased to announce that the Pain Management and Addiction Medicine (PMAM) Section is the recipient of a 2021 Section Award for Service to the College.
January 14, 2021
An eight-year-old male presented to the emergency department (ED) with his mother for left leg pain consistent with his prior sickle cell pain crises episodes. He had first presented two days earlier ...
Lidocaine is an amide-type local anesthetic that exerts its pharmacological action through the blockade of sodium channels in neural tissues, interrupting neuronal transmission.
Chest tube thoracostomy is standard of care for many emergent and non-emergent conditions in the emergency department (ED), including pneumothorax, hemothorax, and empyema.
A 44-year-old male presents to the emergency department (ED) after a motor vehicle collision. He was the restrained driver traveling at highway speeds.
May 19, 2020
On January 23, 2020, the American College of Emergency Physicians (ACEP) convened a summit, “Addressing the Opioid Stigma in the Emergency Department.”
Headache is one of the most common reasons for presentation to an emergency department (ED). In the United States, headache accounts for 3% of all visits.1 Headaches can either be primary or secondary...
Dopamine antagonist (D2-R antagonist) from the butyrophenone family, a class of medications commonly known for their antipsychotic effects.
At 11:00 pm on a Saturday overnight, between the weekend warriors who had sipped a bit too much and the 68-year-old smoker who had developed a fever after two weeks of a worsening cough, a 32-year-old...
First, I want to take this moment to tell you all what an amazing group of doctors you are.
September 23, 2019
The endocannabinoid system in involved in pain modulation through direct and synergistic effects on descending supraspinal pathways involving endocannabinoids, TRPV, PPAR, endorphins, enkaphalin and i...
As discussed in a recent “ACEP 911, Legislative Network Weekly Update” newsletter, there are now bills in the US House (HR 2482) and the US Senate (SR 2074) which seek to “deregulate” buprenorphine pr...
September 19, 2018
Lidocaine as an opiate sparing analgesic: In an unblinded study of 32 patients with undifferentiated pain who received 1.5 mg/kg of IV lidocaine over 10 minutes then randomized to receive the same dos...
The opioid epidemic continues to claim lives. While physicians have drastically changed their prescribing efforts, and prescribing laws have changed to reduce prescription opioid exposure, illicit opi...
A brief note to tell you all how proud I am to be affiliated with this esteemed group. You all amaze me. The number and diversity of projects underway by members of this section is simply mind-blowing...
The U.S. House of Representatives spent two weeks in June completing floor consideration on bills to help address the opioid epidemic, which was the culmination of months of legislative hearings and m...
American College of Emergency Physicians
